The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGulf Marine Services Regulatory News (GMS)

Share Price Information for Gulf Marine Services (GMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.50
Bid: 21.30
Ask: 21.70
Change: 0.40 (1.90%)
Spread: 0.40 (1.878%)
Open: 21.10
High: 21.50
Low: 21.00
Prev. Close: 21.10
GMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Gulf Marine Services plc

1 May 2020 14:17

Aberforth Partners LLP - Form 8.3 - Gulf Marine Services plc

Aberforth Partners LLP - Form 8.3 - Gulf Marine Services plc

PR Newswire

London, May 1

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON

WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Aberforth Partners LLP, on behalf of discretionary clients.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Gulf Marine Services plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 30/04/2020
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”YES / NO / N/A NO If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary Shares
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled: 69,831,569 19.92% 0 0.0
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL: 69,831,569 19.92% 0 0.0

Aberforth Partners LLP does not have discretion regarding voting decisions in respect of 23,449,440 shares included in the total disclosed above. This total includes 23,449,440 shares held by The Wellcome Trust, who retain voting control over their shareholding. No other client, who falls into this category, holds more than 1% of the relevant security.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:N/A
Details, including nature of the rights concerned and relevant percentages:N/A

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
N/A- Opening Disclosure

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/A

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure: 01 May 2020
Contact name:Michael Campbell, for Aberforth Partners LLP
Telephone number:0131 220 0733

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
20th Dec 20214:36 pmRNSPrice Monitoring Extension
13th Dec 20214:41 pmRNSSecond Price Monitoring Extn
13th Dec 20214:35 pmRNSPrice Monitoring Extension
11th Nov 20217:00 amRNSContract
4th Nov 20214:40 pmRNSSecond Price Monitoring Extn
4th Nov 20214:35 pmRNSPrice Monitoring Extension
21st Oct 20217:00 amRNSContract
13th Oct 20213:17 pmRNSShare Purchase by a Director
13th Oct 20217:00 amRNSHalf-year Report
1st Oct 20217:00 amRNSResults Release Date & Trading Update
23rd Aug 20217:00 amRNSAppointment of Non-Executive Director
8th Jul 20211:08 pmRNSDirector/PDMR Shareholding
5th Jul 20212:02 pmRNSDirector/PDMR Shareholding
5th Jul 202110:52 amRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSDirector/PDMR Shareholding
30th Jun 20214:30 pmRNSTotal Voting Rights
30th Jun 20211:42 pmRNSResult of AGM
30th Jun 20217:00 amRNSContract
29th Jun 20213:25 pmRNSTR-1
25th Jun 202112:15 pmRNSResult of General Meeting
25th Jun 20217:00 amRNSResult of Open Offer
11th Jun 202112:36 pmRNSTR1
9th Jun 20215:35 pmRNSPublication of Prospectus and General Meeting
9th Jun 20213:42 pmRNSSuccessful completion of Accelerated Bookbuild
9th Jun 20217:00 amRNSProposed Placing and Open Offer
2nd Jun 20214:35 pmRNSPrice Monitoring Extension
2nd Jun 20214:13 pmRNS2020 Annual Report & Notice of 2021 AGM
26th May 20217:00 amRNSDirectorate Change
25th May 20217:30 amRNSTR-1
24th May 202112:32 pmRNSHolding(s) in Company
24th May 20217:00 amRNSPublication of 2020 Annual Report
20th May 20214:40 pmRNSSecond Price Monitoring Extn
20th May 20214:35 pmRNSPrice Monitoring Extension
14th May 20217:00 amRNSFinancial Results (unaudited)
7th May 20217:00 amRNSNotice of Results
4th May 20217:00 amRNSNew Contract Win
15th Apr 20213:00 pmRNSResults Release Date & Trading Update
1st Apr 20217:00 amRNSNew Debt Deal
23rd Mar 20214:36 pmRNSPrice Monitoring Extension
19th Mar 20214:41 pmRNSSecond Price Monitoring Extn
19th Mar 20214:36 pmRNSPrice Monitoring Extension
16th Mar 20217:00 amRNSImproved Debt Agreement & Trading Update
2nd Mar 20214:41 pmRNSSecond Price Monitoring Extn
2nd Mar 20214:35 pmRNSPrice Monitoring Extension
1st Mar 20217:00 amRNSExtension for improved terms for debt structure
5th Feb 20214:41 pmRNSSecond Price Monitoring Extn
5th Feb 20214:35 pmRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSBoard Change and New Appointment
2nd Feb 20213:01 pmRNSMr Saeed Mir Abdulla Khoory Non-Executive Director
1st Feb 20217:00 amRNSExtension for improved terms for debt structure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.